Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Trans. S. Klein. Boston, MA: American Botanical Council, 1998.

Lewis SJ, Freedman AR. Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease. Aliment Pharmacol Ther 1998;12:807-22. View abstract.

Rabinowitz MB, Gonick HC, Levin SR, Davidson MB. Effects of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men. Diabetes Care 1983;6:319-27. View abstract.

Kovacs DJ, Berk T. Recurrent Clostridium difficile-associated diarrhea and colitis treated with saccharomyces cerevisiae (baker's yeast) in combination with antibiotic therapy. A case report. J Am Board Fam Pract 2000;13:138-40. View abstract.

Hallmark MA, Reynolds TH, DeSouza CA, et al. Effects of chromium and resistive training on muscle strength and body composition. Med Sci Sports Exerc 1996;28:139-44. View abstract.

Minerals for diabetes. Pharmacist's Letter/Prescriber's Letter 2000;16(2):160212.

Hennequin C, Thierry A, Richard GF, et al. Microsatellite typing as a new tool for identification of Saccharomyces cerevisiae strains. J Clin Microbiol 2001;39:551-9. View abstract.

Alic M. Baker's yeast in Crohn's disease—can it kill you? Am J Gastroenterol 1999;94:1711. View abstract.

Facchinetti F, Nappi RE, Sances MG, et al. Effects of a yeast-based dietary supplementation on premenstrual syndrome. A double-blind placebo-controlled study. Gynecol Obstet Invest 1997;43:120-4. View abstract.

Sinai Y, Kaplun A, Hai Y, Halperin B. Enhancement of resistance to infectious diseases by oral administration of brewer's yeast. Infect Immun 1974;9:781-7. View abstract.

Schrauzer GN. Lithium: occurrence, dietary intakes, nutritional essentiality. J Am Coll Nutr 2002;21:14-21.. View abstract.

Borriello SP, Hammes WP, Holzapfel W, et al. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003;36:775-80. View abstract.

Saner G, Yuzbasiyan V, Neyzi O, et al. Alterations of chromium metabolism and effect of chromium supplementation in Turner's syndrome patients. Am J Clin Nutr 1983;38:574-8. View abstract.

Munoz P, Bouza E, Cuenca-Estrella M, et al. Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis 2005;40:1625-34. View abstract.

Moyad MA, Robinson LE, Zawada ET Jr, et al. Effects of a modified yeast supplement on cold/flu symptoms. Urol Nurs 2008;28:50-5. View abstract.

Bahijiri, S. M., Mira, S. A., Mufti, A. M., and Ajabnoor, M. A. The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes. Saudi.Med.J. 2000;21(9):831-837. View abstract.

Bahijri, S. M. and Mufti, A. M. Beneficial effects of chromium in people with type 2 diabetes, and urinary chromium response to glucose load as a possible indicator of status. Biol.Trace Elem.Res. 2002;85(2):97-109. View abstract.

Subbiah, M. T. and Abplanalp, W. Ergosterol (major sterol of baker's and brewer's yeast extracts) inhibits the growth of human breast cancer cells in vitro and the potential role of its oxidation products. Int.J.Vitam.Nutr.Res. 2003;73(1):19-23. View abstract.

Offenbacher, E. G. Chromium in the elderly. Biol.Trace Elem.Res. 1992;32:123-131. View abstract.

Ghoneum, M. and Gollapudi, S. Induction of apoptosis in breast cancer cells by Saccharomyces cerevisiae, the baker's yeast, in vitro. Anticancer Res. 2004;24(3a):1455-1463. View abstract.

Ghoneum, M., Hamilton, J., Brown, J., and Gollapudi, S. Human squamous cell carcinoma of the tongue and colon undergoes apoptosis upon phagocytosis of Saccharomyces cerevisiae, the baker's yeast, in vitro. Anticancer Res. 2005;25(2A):981-989. View abstract.

Elias, A. N., Grossman, M. K., and Valenta, L. J. Use of the artificial beta cell (ABC) in the assessment of peripheral insulin sensitivity: effect of chromium supplementation in diabetic patients. Gen.Pharmacol. 1984;15(6):535-539. View abstract.

Liu, V. J. and Morris, J. S. Relative chromium response as an indicator of chromium status. Am.J Clin.Nutr. 1978;31(6):972-976. View abstract.

Hayter, J. Trace elements: implications for nursing. J Adv.Nurs. 1980;5(1):91-101. View abstract.

Anderson, R. A. Nutritional role of chromium. Sci Total Environ. 1981;17(1):13-29. View abstract.

Elwood, J. C., Nash, D. T., and Streeten, D. H. Effect of high-chromium brewer's yeast on human serum lipids. J.Am.Coll.Nutr. 1982;1(3):263-274. View abstract.

Schrauzer, G. N. and de, Vroey E. Effects of nutritional lithium supplementation on mood. A placebo-controlled study with former drug users. Biol.Trace Elem.Res. 1994;40(1):89-101. View abstract.

Jensen, D. P. and Smith, D. L. Fever of unknown origin secondary to brewer's yeast ingestion. Arch.Intern.Med. 1976;136(3):332-333. View abstract.

Li, Y. C. Effects of brewer's yeast on glucose tolerance and serum lipids in Chinese adults. Biol.Trace Elem.Res. 1994;41(3):341-347. View abstract.

Rolls, R. Brewer's yeast and diabetes. Br.Med.J. 4-2-1977;1(6065):905. View abstract.

Kimura, K. [Role of essential trace elements in the disturbance of carbohydrate metabolism]. Nippon Rinsho 1996;54(1):79-84. View abstract.

Babu, S. and Srikantia, S. G. Availability of folates from some foods. Am.J Clin.Nutr. 1976;29(4):376-379. View abstract.

Roberfroid MB. Prebiotics and probiotics: are they functional foods? Am J Clin Nutr. 2000;71(6 Suppl):1682S-7S; discussion 1688S-90S. View abstract.

Moyad MA, Robinson LE, Kittelsrud JM, et al. Immunogenic yeast-based fermentation product reduces allergic rhinitis-induced nasal congestion: a randomized, double-blind, placebo-controlled trial. Adv Ther. 2009;26(8):795-804. View abstract.

Moyad MA, Robinson LE, Zawada ET, et al. Immunogenic yeast-based fermentate for cold/flu-like symptoms in nonvaccinated individuals. J Altern Complement Med. 2010;16(2):213-218. View abstract.

Jensen GS, et al. Antioxidant bioavailability and rapid immune-modulating effects after consumption of a single acute dose of a high-metabolite yeast immunogen: results of a placebo-controlled double-blinded crossover pilot study. J Med Food. 2011;14(9):1002-1010. View abstract.

Ferreira IMPLVO, Pinho O, Vieira E, Tavarela JG. Brewer's Saccharomyces yeast biomass: characteristics and potential applications. Trends Food Sci Technol. 2010;21(2):77-84.

Cayzeele-Decherf A, Pélerin F, Leuillet S, et al. Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis. World J Gastroenterol. 2017 Jan 14;23(2):336-344. doi: 10.3748/wjg.v23.i2.336. View abstract.

Popiel KY, Wong P, Lee MJ, Langelier M, Sheppard DC, Vinh DC. Invasive Saccharomyces cerevisiae in a liver transplant patient: case report and review of infection in transplant recipients.. Transpl Infect Dis. 2015 Jun;17(3):435-41. doi: 10.1111/tid.12384. View abstract.

Pruccoli G, Silvestro E, Pace Napoleone C, Aidala E, Garazzino S, Scolfaro C. Are probiotics safe? Bifidobacterium bacteremia in a child with severe heart failure. Infez Med. 2019;27(2):175-178. View abstract.

Gayathri R, Aruna T, Malar S, Shilpa B, Dhanasekar KR. Efficacy of Saccharomyces cerevisiae CNCM I-3856 as an add-on therapy for irritable bowel syndrome. Int J Colorectal Dis. 2020;35(1):139-145. View abstract.

Salminen, S., Collado, M.C., Endo, A. et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. May 2021. View abstract.

Mourey F, Decherf A, Jeanne JF, et al. Saccharomyces cerevisiae I-3856 in irritable bowel syndrome with predominant constipation. World J Gastroenterol 2022;28(22):2509-2522. View abstract.

Cahill JA, Tan K, Kan M. Anaphylaxis to a particular brew of beer due to specific strains of Saccharomyces cerevisiae. Ann Allergy Asthma Immunol 2022;128(6):621-623. View abstract.

Poindexter B; Committee on fetus and newborn. Use of Probiotics in Preterm Infants. Pediatrics. 2021;147(6):e2021051485. View abstract.

US Food and Drug Administration (FDA). Dear Healthcare Provider Letter: Warning Regarding Use of Probiotics in Preterm Infants. September 2023. Available at: https://www.fda.gov/media/172606/download?attachment. Accessed November 1, 2023.

Pillai A, Tan J, Paquette V, Panczuk J. Does probiotic bacteremia in premature infants impact clinically relevant outcomes? A case report and updated review of literature. Clin Nutr ESPEN. 2020;39:255-259. View abstract.

Dani C, Coviello C C, Corsini I I, Arena F, Antonelli A, Rossolini GM. Lactobacillus Sepsis and Probiotic Therapy in Newborns: Two New Cases and Literature Review. AJP Rep. 2016;6(1):e25-9. View abstract.

Zbinden A, Zbinden R, Berger C, Arlettaz R. Case series of Bifidobacterium longum bacteremia in three preterm infants on probiotic therapy. Neonatology 2015;107(1):56-9. View abstract.

Bertelli C, Pillonel T, Torregrossa A, et al. Bifidobacterium longum bacteremia in preterm infants receiving probiotics. Clin Infect Dis 2015;60(6):924-7. View abstract.

Esaiassen E, Cavanagh P, Hjerde E, Simonsen GS, Støen R, Klingenberg C. Bifidobacterium longum subspecies infantis bacteremia in 3 extremely preterm infants receiving probiotics. Emerg Infect Dis 2016;22(9):1664-6. View abstract.